| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | ENDOLOGIX INC | 40,941,000 | 39,784,000 | 1.33% | PRN | |
| 102 | EHEALTH INC COM | 3,264,588 | 41,428,000 | 1.38% | ||
| 103 | CHARLES RIV LABS INTL INC | 611,436 | 43,008,000 | 1.43% | ||
| 104 | GW PHARMACEUTICALS PLC | 361,953 | 44,462,000 | 1.48% | ||
| 105 | UNIVERSAL AMERN CORP NEW | 4,409,703 | 44,626,000 | 1.49% | ||
| 106 | AETNA INC NEW | 369,739 | 47,127,000 | 1.57% | ||
| 107 | DAVITA INC | 636,000 | 50,543,000 | 1.68% | ||
| 108 | WALGREENS BOOTS ALLIANCE INC | 648,501 | 54,759,000 | 1.82% | ||
| 109 | BLUEBIRD BIO INC COM | 326,783 | 55,020,000 | 1.83% | ||
| 110 | Nivalis Therapeutics Inc | 3,732,412 | 56,546,000 | 1.88% | ||
| 111 | ARRAY BIOPHARMA INC 3 06/01/2020 | 45,000,000 | 56,942,000 | 1.90% | PRN | |
| 112 | GLAXOSMITHKLINE PLC | 1,376,722 | 57,340,000 | 1.91% | ||
| 113 | MYLAN N V | 871,000 | 59,106,000 | 1.97% | ||
| 114 | VANDA PHARMACEUTICALS INC COM | 4,784,157 | 60,711,000 | 2.02% | ||
| 115 | DYAX CORP COM CVR | 2,483,507 | 65,813,000 | 2.19% | ||
| 116 | ARRAY BIOPHARMA INC | 9,529,361 | 68,707,000 | 2.29% | ||
| 117 | NXSTAGE MED INC COM | 5,773,050 | 82,468,000 | 2.75% | ||
| 118 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 4,072,809 | 86,303,000 | 2.88% | ||
| 119 | ALLSCRIPTS HEALTHCARE SOLUTN | 100,750,000 | 103,524,000 | 3.45% | PRN | |
| 120 | HORIZON PHARMA PLC | 12,259,875 | 425,908,000 | 14.19% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-15-032279, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
